AAPL 244.6 1.2711% MSFT 408.43 -0.514% NVDA 138.85 2.6314% GOOGL 185.23 -0.4889% GOOG 186.87 -0.5376% AMZN 228.68 -0.7336% META 736.67 1.1132% AVGO 233.04 -1.1705% LLY 844.27 -2.9976% TSLA 355.84 -0.0281% TSM 203.9 1.0256% V 353.81 -0.5118% JPM 276.59 0.0977% UNH 523.51 -1.444% NVO 77.87 -1.2178% WMT 104.04 -0.9614% LVMUY 149.83 0.7193% XOM 108.24 0.1017% LVMHF 752.0 1.2059% MA 564.76 -0.2737%
Last update at 2025-02-14T21:10:00Z
Bio-Rad Laboratories Full Year 2024 Earnings: EPS Misses Expectations
Sat 15 Feb 25, 01:03 PMBIO Q4 Earnings and Revenues Miss Estimates, Stock Down Aftermarket
Fri 14 Feb 25, 06:57 PMQ4 2024 Bio Rad Laboratories Inc Earnings Call
Fri 14 Feb 25, 12:10 PMJohn Rogers' Strategic Moves: A Closer Look at Royal Caribbean Group's Impact
Fri 14 Feb 25, 12:03 PMBruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls
Fri 14 Feb 25, 10:42 AMBio-Rad Laboratories Inc (BIO) Q4 2024 Earnings Call Highlights: Navigating Challenges with ...
Fri 14 Feb 25, 07:22 AMBio-Rad Laboratories (BIO) Misses Q4 Earnings and Revenue Estimates
Thu 13 Feb 25, 10:45 PMBio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results
Thu 13 Feb 25, 09:20 PMBio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies
Thu 13 Feb 25, 09:15 PMCVS Health Stock Up on Q4 Earnings & Revenue Beat, Margins Rise
Wed 12 Feb 25, 01:37 PMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | -4704.27300M | 5438.15M | 4907.64M | 2261.08M | 507.36M |
Minority interest | - | - | - | - | - |
Net income | -3627.53500M | 4245.90M | 3806.27M | 1758.67M | 361.00M |
Selling general administrative | 827.83M | 879.57M | 800.27M | 824.62M | 834.78M |
Selling and marketing expenses | - | - | - | - | 1.49M |
Gross profit | 1567.33M | 1640.66M | 1437.82M | 1257.00M | 1224.36M |
Reconciled depreciation | 137.30M | 133.80M | 138.10M | 134.20M | 138.10M |
Ebit | 482.62M | 489.43M | 410.96M | 229.66M | 228.47M |
Ebitda | 664.49M | 650.01M | 573.57M | 389.99M | 366.55M |
Depreciation and amortization | 181.87M | 160.58M | 162.62M | 160.33M | 138.09M |
Non operating income net other | 44.78M | 24.02M | 22.72M | 23.85M | 33.73M |
Operating income | 482.62M | 489.43M | 410.96M | 229.66M | -108.64100M |
Other operating expenses | 2319.63M | 2433.11M | 2134.67M | 2082.00M | 2098.24M |
Interest expense | 38.11M | 1.55M | 21.86M | 23.42M | 23.96M |
Tax provision | -1076.73800M | 1192.25M | 1101.37M | 502.41M | 147.04M |
Interest income | 58.00M | 4921.94M | 4491.39M | 30.50M | 26.60M |
Net interest income | 19.89M | -1.55100M | -21.86100M | 7.08M | 2.64M |
Extraordinary items | - | - | - | - | 49.00M |
Non recurring | - | - | - | - | 292.51M |
Other items | - | - | - | - | - |
Income tax expense | -1076.73800M | 1192.25M | 1101.37M | 502.41M | 146.36M |
Total revenue | 2802.25M | 2922.55M | 2545.63M | 2311.66M | 2290.11M |
Total operating expenses | 1084.71M | 1151.23M | 1026.87M | 1027.34M | 1032.49M |
Cost of revenue | 1234.92M | 1281.88M | 1107.80M | 1054.66M | 1065.75M |
Total other income expense net | -5186.88900M | 4948.72M | 4496.68M | 2031.42M | 339.45M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | -3627.53500M | 4245.90M | 3806.27M | 1758.67M | 365.61M |
Net income applicable to common shares | -3627.53500M | 4245.90M | 3806.27M | 1758.67M | 365.61M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Total assets | 12299.07M | 13501.67M | 17775.79M | 12972.62M | 8008.86M |
Intangible assets | 320.48M | 332.15M | 253.94M | 199.50M | 145.53M |
Earning assets | - | - | - | - | - |
Other current assets | 171.65M | 147.78M | 117.83M | 101.48M | 113.27M |
Total liab | 3557.94M | 3886.41M | 4108.66M | 3092.68M | 2253.80M |
Total stockholder equity | 8741.13M | 9615.25M | 13667.13M | 9879.94M | 5755.06M |